News
FDA unveils fast-track review path for 'national priorities'
The Commissioner's National Priority Voucher (CNPV) programme will be available to companies aligned with pressing matters such as addressing a national health crisis, delivering more innovative cures, addressing unmet public health needs, or increasing domestic drug manufacturing as a national security issue.
All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...
Pharmaceutical Technology on MSN14h
FDA Commissioner envisions fewer delays, more clinical trial flexibility and AI useFDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.
And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...
Speaking at BIO 2025, Makary bemoaned what he called “unnecessary steps” and “avoidable delays” in the U.S. regulatory ...
Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...
FDA Commissioner Marty Makary said that one of his key priorities is to modernize the agency by streamlining the drug review ...
One of the country's biggest food manufacturers is getting on board with Health Secretary RFK Jr.'s plans to stop the industry from using synthetic dyes. FDA Commissioner Dr. Marty Makary joins "The ...
Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on ...
Makary and Center for Biologics Evaluation and Research Director Vinay Prasad unveiled a new framework in the New England Journal of Medicine on May 20 requiring a stronger evidence base for boosters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback